Connect Biopharma Holdings Ltd (CNTB) — Strategic Asset Allocation Index
Connect Biopharma Holdings Ltd (CNTB) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $101.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Connect Biopharma Holdings Ltd Strategic Asset Allocation Index (2021–2023)
This chart shows how Connect Biopharma Holdings Ltd's Strategic Asset Allocation Index has evolved across 3 annual periods from 2021 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $101.50 Million USD. Explore Connect Biopharma Holdings Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Connect Biopharma Holdings Ltd (2021–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Connect Biopharma Holdings Ltd from 2021 to 2023, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CNTB market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | $0.00 | $- | $0.00 | $101.50 Million | ▼ -41.7 pp |
| 2022 | 41.7% | $65.74 Million | $- | $65.74 Million | $157.49 Million | ▲ +11.6 pp |
| 2021 | 30.2% | $82.16 Million | $82.16 Million | $0.00 | $272.26 Million | — |